Fanbo Zeng

Ask VT AI
View News Summary
  • Pfizer sues Novo Nordisk to block its $8.5-$9B bid for Metsera, alleging antitrust violations and a 'kill' strategy to preserve dominance in GLP-1 obesity drugs.
  • DaVita's Q3 earnings miss expectations, leading to a decline in share price, as the company faces cost and volume headwinds despite pockets of growth.
  • Dolphins part ways with longtime GM Chris Grier, signaling a broader organizational reset.
20 days
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Pfizer sues Novo Nordisk to block its $8.5-$9B bid for Metsera, alleging antitrust violations and a 'kill' strategy to preserve dominance in GLP-1 obesity drugs.
  • DaVita's Q3 earnings miss expectations, leading to a decline in share price, as the company faces cost and volume headwinds despite pockets of growth.
  • Dolphins part ways with longtime GM Chris Grier, signaling a broader organizational reset.
20 days
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Fanbo Zeng